From October 1, 2023 to December 31, 2023, the company has repurchased 303,400 shares, representing 0.18% for CNY 3.9 million. With this, the company has completed the repurchase of 724,500 shares, representing 0.42% for CNY 8.97 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.11 CNY | -4.06% |
|
+0.82% | -23.75% |
1st Jan change | Capi. | |
---|---|---|
-23.75% | 259M | |
+20.75% | 8.68B | |
-0.67% | 6.71B | |
-15.91% | 4.97B | |
-7.63% | 3.66B | |
-22.78% | 3.08B | |
-17.39% | 1.13B | |
-26.21% | 1.13B | |
-1.04% | 953M | |
-15.62% | 862M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.